Current status of linkage studies in hereditary prostate cancer

BJU International

Volumn 86, Issue 6, 2000, Pages 659-669

  Karayi, M K ^a   Neal, D E ^b,c   Markham, A F ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Department of Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SUSCEPTIBILITY; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME XQ; DISEASE COURSE; GENE LOCUS; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; HUMAN; LINKAGE (GENETICS); MALE; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; X CHROMOSOME;

EID: 0033772159     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00837.x     Document Type: Review

References (109)

1. Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet 1955; 7: 277-318
2. Ott J. Methods of linkage analysis. Analysis of Human Genetic Linkage. Chapt 4. Baltimore: The Johns Hopkins University Press, 1991: 54-81
3. Terwilliger J, Ott J. Exclusion mapping. Handbook for Human Genetic Linkage, Chapt 17. Baltimore: The Johns Hopkins University Press, 1994: 135-8
4. Spence MA. Genetic linkage: sampling issues and multipoint mapping. J Psychiatr Res 1987; 21: 631-7
5. Strachan T, Read AP. Genetic mapping of complex character. In Human Molecular Genetics. 2nd edn, Chapt 12. Oxford: BIOS Scientific Publishers, 1999: 283-94
6. Elston RC. Segregation analysis. Adv Hum Genet 1981; 11: 63-120
7. Pulst SM. Genetic linkage analysis. Arch Neurol 1999; 56: 667-72
8. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1996; 46: 5-27
9. Carter BS, Bova GS, Beaty TH et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150: 797-802
10. Smith JR, Freije D, Carpten JD et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 1371-4
11. Carter BS, Steinberg GD, Beaty TH, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-71
12. Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. Cancer 1996; 77: 138-43
13. Gronberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 1997; 146: 552-7
14. Berthon P, Valeri A, Cohen-Akenine A et al. Predisposing gene for early-onset prostate cancer, localised on chromosome 1q42.2-43. Am J Hum Genet 1998; 62: 1416-24
15. Gibbs M, Stanford JL, McIndoe RA et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999; 64: 776-87
16. Xu J, Meyers D, Freije D et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 175-9
17. Gronberg H, Xu J, Smith JR et al. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res 1997; 57: 4707-9
18. McIndoe RA, Stanford JL, Gibbs M et al. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997; 61: 347-53
19. Eeles RA, Durocher F, Edwards S et al. Linkage Analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group UK Familial Prostate Cancer Study Collaborators. Am J Hum Genet 1998; 62: 653-8
20. Gibbs M, Chakrabarti L, Stanford JL et al. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am J Hum Genet 1999; 64: 1087-95
21. Cooney KA, McCarthy JD, Lange E et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997; 89: 955-9
22. Gronberg H, Isaacs SD, Smith JR et al. Characteristics of prostate cancer in families potentially linked to the HPC1 locus. JAMA 1997; 278: 1251-5
23. Gronberg H, Smith J, Emanuelsson M et al. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet 1999; 65: 134-40
24. Hsieh CL, Oakley-Girvan I, Gallagher RP et al. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997; 89: 1893-4
25. Thibodeau SN, Wang Z, Tester DJ et al. Linkage analysis at the HPC1 locus in hereditary prostate cancer families. Am J Hum Genet 1997; 61 (Suppl): A297
26. Schleutker J, Matikainen M, Baffoe-Bonnie A et al. HPCX (Xq27-28) linkage is common among Finnish prostate cancer families: Strong association with late onset disease. Am J Hum Genet 1999; Suppl. 65: A86(453)
27. Dunsmuir WD, Edwards SM, Lakhani SR et al. The CRC/BPG UK Familial Prostate Cancer Study Collaborators and Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate susceptibility locus, HPC1. Br J Cancer 1998; 78: 1430-3
28. Cher ML, Bova GS, Moore DH et al. Genetic alteration in untreated metastases and androgen independent prostate cancer detected by CGH and allelotyping. Cancer Res 1996; 56: 3091-102
29. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. In SEER Cancer Statistics Review. 1973-96, National Cancer Institute, Bethesda, MD 1999 (Table and graphs at http://www-seer.ims.nci.nih.gov/Publications/)
30. Berry R, Schaid DJ, Smith JR et al. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. Am J Hum Genet 2000; 66: 539-46
31. Xu J and the International Consortium for Prostate Cancer Genetics. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for the prostate cancer genetics. Am J Hum Genet 2000; 66: 945-57
32. Hall JM, Lee MK, Newman B et al. Linkage analysis of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-9
33. Easton DF, Bishop DT, Ford D, Crockford GP and the Breast Cancer Linkage Consortium. Genetic analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701
34. Wooster R, Neuhausen SL, Mangion J et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90
35. Johannsson O, Ostermeyer EA, Hakansson S et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am J Hum Genet 1996; 58: 441-50
36. Wijnen J, Khan PM, Vasen H et al. HNPCC families not complying with the Amsterdam criteria show extremely low frequency of MMR gene mutations. Am J Hum Genet 1997; 61: 329-35
37. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232-42
38. Gronberg H, Damber L, Tavelin B, Damber JE. No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol 1998; 82: 564-7
39. Keetch DW, Humphrey PA, Smith DS, Stahl D, Catalona WJ. Clinical and pathological features of hereditary prostate cancer. J Urol 1996; 155: 1841-3
40. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI. Pathological features of hereditary prostate cancer. J Urol 1995; 153: 987-92
41. Rodriguez C, Calle EE, Miracle-McMahill HL et al. Family history and risk of fatal prostate cancer. Epidemiology 1997; 8: 653-7
42. Bova GS, Partin AW, Isaacs SD et al. Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol 1998; 160: 660-3
43. Suarez BK, Lin J, Burmester JK et al. A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 2000; 66: 933-44
44. Carpten JD, Makalowska I, Robbins CM et al. A 6-Mb high resolution physical and transcriptional map encompassing the hereditary prostate cancer 1 (HPC1) region. Genomics 2000; 64: 1-14
45. Kruh GD, King CR, Kraus MH et al. A novel human gene closely related to the abl proto-oncogene. Science 1986; 234: 1545-8
46. Kruh GD, Perego R, Miki T, Aaronson SA. The complete coding sequence of ARG defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci USA 1990; 87: 5802-6
47. Le Bouffant F, Capdevielle J, Guillemot JC, Sladeczek F. Characterization of brain PCTAIRE-1 kinase immunoreactivity and its interactions with p11 and 14-3-3 proteins. Eur J Biochem 1998; 257: 112-20
48. Sawzdargo M, Nguyen T, Lee DK et al. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 1999; 64: 193-8
49. Noto S, Maeda T, Hattori S et al. A novel human RasGAP-like gene that maps within the prostate cancer susceptibility locus at chromosome 1q25. FEBS Lett 1998; 441: 127-31
50. Snow BE, Antonio L, Suggs S, Siderovski DP. Cloning of a retinally abundant regulator of G-protein signalling (RGS-r/RGS16): genomic structure and chromosomal localization of the human gene. Gene 1998; 206: 247-53
51. Coppock DL, Cina-Poppe D, Gilleran S. The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. Genomics 1998; 54: 460-8
52. Wang X, Ray K, Szpirer J, Levan G, Liebhaber SA, Cooke NE. Analysis of the human cysteine-rich protein gene (CSRP), assignment to chromosome 1q24-1q32, and identification of an associated MspI polymorphism. Genomics 1992; 14: 391-7
53. Morris CM, Hao QL, Heisterkamp N, Fitzgerald PH, Groffen J. Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24. Oncogens 1991; 6: 1093-5
54. Puchacz E, Lian JB, Stein GS, Wozney J, Huebner K, Croce C. Chromosomal localization of the human osteocalcin gene. Endocrinology 1989; 124: 2648-50
55. Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K. Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics 1995; 26: 138-41
56. Hashimoto K, Hirai M, Kurosawa Y. A gene outside the human MHC related to classical HLA class I genes. Science 1995; 269: 693-5
57. Yamaguchi H, Hirai M, Kurosawa Y, Hashimoto K. A highly conserved major histocompatibility complex class I-related gene in mammals. Biochem Biophys Res Commun 1997; 238: 697-702
58. Allikmets R, Gerrard B, Glavac D et al. Characterization and mapping of three new mammalian ATP-binding transporter genes from an EST database. Mamm Genome 1995; 6: 114-7
59. 2+-transporting ATPases to human chromosomes 1q25-32 and 12q21-23. Genomics 1991; 9: 629-41
60. Fukushima Y, Pikkarainen T, Kallunki T et al. Isolation of a human laminin B2 (LAMB2) cDNA clone and assignment of the gene to chromosome region 1q25-q31. Cytogenet Cell Genet 1988; 48: 137-41
61. Whittemore AS, Lin IG, Oakley-Girvan I et al. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. Am J Hum Genet 1999; 65: 254-6
62. Narod SA, Ford D, Devilee P et al. Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 1995; 57: 957-8
63. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62: 676-89
64. Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumour antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci USA 1996: 93: 7252-7
65. Baumgartner M, Schneider R, Auer B, Herzog H, Schweiger M, Hirsch-Kauffmann M. Fluorescence in situ mapping of the human nuclear NAD+ ADP-ribosyltransferase gene (ADPRT) and two secondary sites to human chromosomal bands 1q42, 13q34, and 14q24. Cutoaenet Cell Genet 1992; 61: 172-4
66. Rousseau-Merck MF, Zahraoui A, Touchot N, Tavitian A, Berger R. Chromosome assignment of four RAS-related RAB genes. Hum Genet 1991; 86: 350-4
67. Feichtinger W, Schmid M. Increased frequencies of sister chromatid exchanges at common fragile sites 1q42 and 19q13. Hum Genet 1989; 83: 145-7
68. Murty VV, Li RG, Mathew S et al. Replication error-type genetic instability at 1q42-43 in human male germ cell tumours. Cancer Res 1994; 54: 3983-5
69. Li YS, Ramsay DA, Fan YS, Armstrong RF, Del Maestro RF. Cytogenetic evidence that a tumour suppressor gene in the long arm of chromosome 1 contributes to glioma growth. Cancer Genet Cytogenet 1995; 84: 46-50
70. Parvari R, Hershkovitz E, Kanis A et al. Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42-43. Am J Hum Genet 1998; 63: 163-9
71. Lesage F, Mattei M, Fink M, Barhanin J, Lazdunski M. Assignment of the human weak inward rectifier K+ channel TWIK-1 gene to chromosome 1q42-q43. Ceramics 1996; 34: 153-5
72. Vojta PJ, Futreal PA, Annab LA, Kato H, Pereira-Smith OM, Barrett JC. Evidence for two senescence loci on human chromosome 1. Genes Chromosomes Cancer 1996; 16: 55-63
73. White PS, Maris JM, Beltinger C et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995; 92: 5520-4
74. Kaghad M, Bonnet H, Yang A et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other cancers. Cell 1997; 90: 809-19
75. Gururajan R, Grenet J, Lahti JM, Kidd VJ. Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3. Ceramics 1998; 52: 101-6
76. Buyse IM, Takahashi EI, Huang S. Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics 1996; 34: 119-21
77. Bale SJ, Dracopoli NC, Tucker MA et al. Mapping the gene for hereditary cutaneous malignant, melanoma-dysplastic nevus tochromosome 1p. N Engl J Med 1989; 320: 1367-72
78. Loiseau H, Arsaut J, Demotes-Mainard J. p73 gene transcripts in human brain tumours: overexpression and altered splicing in ependymomas. Neurosi Lett 1999; 263: 173-6
79. Imyanitov EN, Birrell GW, Filippovich I et al. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target. Oncogene 1999; 18: 4640-2
80. Schwab M. Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas. Brain Pathol 1990; 1: 41-6
81. Hadano S, Nasir J, Nichol K et al. Genomic organization of the human caspase-9 gene on chromosome 1p36.1-p36.3. Mamm Genome 1999; 10: 757-60
82. Eipers PG, Barnoski BL, Han J, Carroll AJ, Kidd VJ. Localization of the expressed human p58 protein kinase chromosomal gene to chromosome 1p36 and a highly related sequence to chromosome 15. Genomics 1991; 11: 621-9
83. Velasco G, Pendas AM, Fueyo A, Knauper V, Murphy G, Lopez-Otin C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 1999; 274: 4570-6
84. Shapiro DN, Sublett JE, Li B et al. The gene for PAX7, a member of the paired-box-containing genes, is localized on human chromosome arm 1p36. Ceramics 1993; 17: 767-9
85. Haluska FG, Thiele C, Goldstein A, Tsao H, Benoit EP, Housman D. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines. Int J Cancer 1997; 72: 337-9
86. Schwarz H, Arden K, Lotz M. CD137, a member of the tumour necrosis factor receptor family, is located on chromosome 1p36, in a cluster of related genes, and colocalizes with several malignancies. Biochem Biophys Res Commun 1997; 235: 699-703
87. Kaufman BA, White PS. Brodeur G. A complex single strand conformational polymorphism (SSCP) in the tumour necrosis factor receptor 2 (TNFR2) gene on chromosome 1p36.2. Hum Mol Genet 1993; 2: 824
88. Valdenaire O, Rohrbacher E, Mattei MG. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 1995; 270: 29794-8
89. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y, AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994; 23: 425-32
90. Narod SA, Dupont A, Cusan L et al. The impact of family history on early detection of prostate cancer. Nat Med 1995; 1: 99-101
91. Hayes RB, Liff JM, Pottern LM et al. Prostate cancer risk in US blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 361-4
92. Monroe KR, Yu MC, Kolonel LN et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995; 1: 827-9
93. Whittemore AS, Kolonel LN, Wu AH et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 652-61
94. Whittemore AS, Wu AH, Kolonel LN et al. Family history and prostate cancer risk in Black, White, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141: 732-40
95. Cannon-Albright L, Eeles RA. Progress in prostate cancer. Nat Genet 1995; 9: 336-7
96. Bentel JM, Tilley WD. Androgen receptor in prostate cancer. J Endochnol 1996; 151: 1-11
97. Mandel JL, Monaco AP, Nelson DL, Schlessinger D, Willard H. Genome analysis and the human X chromosome. Science 1992; 258: 103-9
98. Cooney KA, Chen H, Ray ME et al. Linkage analysis of 153 prostate cancer families over a 30 cM region containing the putative susceptibility locus HPCX. Am J Hum Genet 1999; Suppl. 65: A123(652)
99. Peters MA, Jarvik GP, Janer M et al. Genetic linkage of prostate cancer families to Xq27-28. Am J Hum Genet 1999; Suppl. 65: A439(2492)
100. Wang MG, Yi H, Hilflker H, Carafoli E, Strehler EE, McBride OW. Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26 to p25 and Xq28, respectively. Cyto Cell Genet 1994; 67: 41-5
101. Gecz J, Bielby S, Sutherland GR, Mulley JC. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics 1997; 44: 201-13
102. Lethe B, Lucas S, Michaux L et al. LAGE-1, a new gene with tumor specificity. Int J Cancer 1998; 76: 903-8
103. Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T, Yamaguchi K. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett 1999; 140: 227-34
104. Rogner UC, Wilke K, Steck E, Korn B, Poustka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics 1995; 29: 725-31
105. Saugier-Veber P, Martin C, Le Meur N et al. Identification of novel L1CAM mutations using fluorescence-assisted mismatch analysis. Hum Mutat 1998; 12: 259-66
106. Tanaka T, Okui K, Nakamura Y. Assignment of the human caltractin gene (CALT) to Xq28 by fluorescence in situ hybridization. Genomics 1994; 24: 609-10
107. Page WF, Braun MM, Caporaso NE. Ascertainment of mortality in the US veteran population: World War II veteran twins. Mil Med 1995; 160: 351-5
108. Gronberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in a twin population. J Urol 1994; 152: 1484-7
109. Walker B, Figgs LW, Zahm SH. Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect 1995; 103: 275-81